Eudragit coated alginate beads bearing oxaliplatin loaded liposomes: Formulation, optimization and in vitro characterization

Authors

  • Ankita Tiwari Pharmaceutics Research Projects Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar (M.P.), INDIA - 470 003
  • Sanjay K. Jain Pharmaceutics Research Projects Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar (M.P.), INDIA - 470 003

Keywords:

Liposomes

Abstract

Objective: The present investigation aimed to develop and characterize Eudragit S-100 coated alginate beads bearing oxaliplatin loaded liposomes for colon-specific drug delivery. Methods: Liposomes were formulated by the thin-film hydration method. The process and formulation variables were optimized by Box-Behnken design (BBD) with the help of Design-Expert® Software. Three independent variables taken were HSPC:Chol molar ratio (X1), hydration time (X2), and sonication time (X3). The response variables selected were entrapment efficiency of oxaliplatin, polydispersity index, and vesicle size. Results: The liposomes possessed an average particle size of 110.1 ± 2.8 nm, PDI 0.096 ± 0.3, zeta potential of -6.70 ± 1.4 mV, and entrapment efficiency of 27.65%. The beads were characterized for their size, in vitro drug release, and swelling index. The degree of swelling of the beads was found to be 2.3 fold higher at pH 7.4 than at pH 1.2. The in vitro drug release depicted a sustained drug release in 48 hours. Conclusion: The outcomes of the study proposed that the developed system can be effectively used for site-specific drug delivery to the colon via the oral route.

Downloads

Download data is not yet available.

References

Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA: Cancer J. Clin. 2014;64(2):104-17.

Gupta S, Provenzale D, Regenbogen SE, Hampel H, Slavin TP, Hall MJ, et al. NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 3.2017. J Natl Compr Canc Netw. 2017;15(12):1465-75.

Fong CW. Platinum anti-cancer drugs: free radical mechanism of Pt-DNA adduct formation and anti-neoplastic effect. Free Radic. Biol. Med. 2016;95:216-29.

BH JG, Shankar S, Munisamy M, RS A, Sagar V. Development of ph-dependent chronomodulated delivery systems of 5-fluorouracil and oxaliplatin to treat colon cancer. Int J App Pharm. 2020;12(5):118-30.

Perego P, Robert J. Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy. Cancer Chemother Pharmacol. 2016;77(1):5-18.

Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 2005;4(2):145-60.

Atara SA, Soniwala M. Formulation and evaluation of pectin-calcium chloride beads of azathioprine for colon targeted drug delivery system. Int. J. Pharm. Pharm. Sci. 2018;10:172-9.

Ramanathan M, Subramanian L. FORMULATION AND EVALUATION OF COLON TARGETED MATRIX TABLETS OF IBUPROFEN. Asian j. pharm. res. dev. 2018;6(2):9-19.

Madhavi C, Babu PK, Maruthi Y, Parandhama A, Reddy OS, Rao KC, et al. Sodium alginate–locust bean gum IPN hydrogel beads for the controlled delivery of nimesulide-anti-inflammatory drug. Int J Pharm Pharm Sci. 2017;9(10):245-52.

Ferreira SC, Bruns R, Ferreira H, Matos G, David J, Brandão G, et al. Box-Behnken design: an alternative for the optimization of analytical methods. Anal. Chim. Acta. 2007;597(2):179-86.

Bangham AD. Membrane models with phospholipids. Prog. Biophys. Mol. Biol. 1968;18:29-95.

Mezei M, Gulasekharam V. Liposomes—a selective drug delivery system for the topical route of administration: gel dosage form. J. Pharm. Pharmacol. 1982;34(7):473-4.

Alagumurthi N, Palaniradja K, Soundararajan V. Optimization of grinding process through design of experiment (DOE)—A comparative study. Mater. Manuf. Processes. 2006;21(1):19-21.

Giovanni M. Response surface methodology and product optimization. Food Technol. 1983.

Saraf S, Jain A, Tiwari A, Verma A, Jain SK. Engineered liposomes bearing camptothecin analogue for tumour targeting: in vitro and ex-vivo studies. Journal of liposome research. 2020:1-16.

Galpin I, Kenner G, Ohlsen S, Ramage R. Gel filtration of protected peptides on Sephadex G-50 in hexamethylphosphoramide containing 5% water. J. Chromatogr. A. 1975;106(1):125-9.

Jain A, Jain SK, Ganesh N, Barve J, Beg AM. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine: Nanotechnology, Biology and Medicine. 2010;6(1):179-90.

Xing L, Dawei C, Liping X, Rongqing Z. Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome. Journal of Controlled Release. 2003;93(3):293-300.

Huyghebaert N, Vermeire A, Remon JP. In vitro evaluation of coating polymers for enteric coating and human ileal targeting. Int. J. Pharm. 2005;298(1):26-37.

Xie Cl, Lee SS, Choung Sy, Kang SS, Choi YJ. Preparation and optimisation of liposome‐in‐alginate beads containing oyster hydrolysate for sustained release. International Journal of Food Science & Technology. 2016;51(10):2209-16.

Lee B-J, Min G-H. Preparation and release characteristics of polymer-reinforced and coated alginate beads. Archives of Pharmacal Research. 1995;18(3):183-8.

Souder J, Ellenbogen W. Control of d-amphetamine sulphate sustained release capsule. Drug Stand. 1985;26:77-9.

Segale L, Giovannelli L, Mannina P, Pattarino F. Calcium alginate and calcium alginate-chitosan beads containing celecoxib solubilized in a self-emulsifying phase. Scientifica. 2016;2016.

Wang T, Jiang Y, Chu H, Liu X, Dai Y, Wang D. Doxorubicin and Lovastatin co-delivery liposomes for synergistic therapy of liver cancer. J. Drug Deliv. Sci. Technol. 2019;52:452-9.

Yang S, Chen J, Zhao D, Han D, Chen X. Comparative study on preparative methods of DC-Chol/DOPE liposomes and formulation optimization by determining encapsulation efficiency. Int. J. Pharm. 2012;434(1-2):155-60.

Narayan R, Singh M, Ranjan O, Nayak Y, Garg S, Shavi GV, et al. Development of risperidone liposomes for brain targeting through intranasal route. Life Sci. 2016;163:38-45.

Kumari A, Jain A, Hurkat P, Tiwari A, Jain SK. Eudragit S100 coated microsponges for Colon targeting of prednisolone. Drug Dev. Ind. Pharm. 2018;44(6):902-13.

Chaurasia M, Chourasia MK, Jain NK, Jain A, Soni V, Gupta Y, et al. Cross-linked guar gum microspheres: A viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer. AAPS PharmSciTech. 2006;7(3):E143-E51.

Seeli DS, Dhivya S, Selvamurugan N, Prabaharan M. Guar gum succinate-sodium alginate beads as a pH-sensitive carrier for colon-specific drug delivery. Int. J. Biol. Macromol. 2016;91:45-50.

Published

20-09-2021

How to Cite

Tiwari, A., & Jain, S. K. (2021). Eudragit coated alginate beads bearing oxaliplatin loaded liposomes: Formulation, optimization and in vitro characterization. International Journal of Applied Pharmaceutics, 13(6). Retrieved from https://innovareacademics.in/journals/index.php/ijap/article/view/43199

Issue

Section

Original Article(s)